Dr. Sarah J. Rinehart, MD

Dr. Rinehart practices at Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health.

Dr. Rinehart's NPI, 1740494087, was assigned on May 9, 2007. Dr. Rinehart graduated from JC Edwards School of Medicine, Marshall University in 2004. Dr. Rinehart holds West Virginia license 22829.

Dr. Rinehart's primary practice is Charleston Area Medical Center General Hospital, at 501 Morris Street, Charleston, WV 25301 in Kanawha County. The practice phone is (304) 388-5432.

Dr. Rinehart's primary practice is Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health. Dr. Rinehart is also affiliated with Thomas Memorial Hospital. The medical group on file is Charleston Area Medical Center. Dmand AI also links Dr. Rinehart to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rinehart practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rinehart's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Rinehart's licenses on file in 2 states: West Virginia and Georgia.

CMS data shows 1,326 Medicare services from Dr. Rinehart across 12 procedure codes in 2024, for 857 Medicare patients. Medicare paid $62,304 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 857 Medicare patients who saw Dr. Rinehart in 2024. The largest group is 65 to 74, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rinehart's median patient age at 71, with 55% women.

In 2024, Dr. Rinehart wrote 1,221 Medicare Part D claims for 264 patients. 63% of them were for generic drugs. CMS names the drug for 1,054 of them, across 22 drugs with 11 or more claims each, at $433,747 in total drug cost. In 2023, CMS named 510 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Rinehart for performance year 2024, reported through an alternative payment model (APM). Dr. Rinehart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rinehart as offering telehealth.

CMS Open Payments shows 457 general payments to Dr. Rinehart from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. HeartFlow, Inc. paid the most, $284,378. It also lists 4 research payments totaling $5,260 from 2024 to 2025.

Dr. Rinehart graduated from JC Edwards School of Medicine, Marshall University in 2004.